Breaking Down China Petroleum & Chemical Corporation Financial Health: Key Insights for Investors

Investors tracking China Petroleum & Chemical Corporation (0386.HK) should note a sharp revenue contraction - total revenue for H1 2025 was RMB 1.41 trillion, a 54% decline from RMB 3.07 trillion in 2024 - driven in part by a 12.2% drop in refining revenues and a 14.7% year‑on‑year fall in average Platts Brent to USD 71.7 /bbl; profitability also weakened with H1 2025 net profit attributable to shareholders at RMB 23.75 billion (down ~39.5-43.7%), basic EPS at RMB 0.196 versus RMB 0.415 in 2024, and a 2024 operating profit of RMB 70.686 billion (margin ~2.3%), even as operating cash flow remained robust (RMB 149.36 billion in 2024 and RMB 61.016 billion in H1 2025, up 44.4%); balance‑sheet and capital allocation moves include total 2025 capex of RMB 164.3 billion (E&P capex RMB 76.7 billion), repurchases of 37.77 million H shares and 48.82 million A shares (not yet cancelled as of Oct 2025), and a maintained total payout ratio of 75% in 2024, while operational volumes show resilience - 252 million tonnes of crude processed and 153 million tonnes of refined products in 2024 (gasoline +2.6%, kerosene +8.6%) - so read on for a detailed breakdown of liquidity, leverage, valuation implications and the key risks and growth vectors shaping the company's financial health.

China Petroleum & Chemical Corporation (0386.HK) - Revenue Analysis

• H1 2025 total revenue: RMB 1.41 trillion (vs RMB 3.07 trillion in 2024; -54% YoY)
• Refining segment revenue change: -12.2% YoY
• 2024 total payout ratio: 75% (maintained shareholder returns despite earnings pressure)
• Domestic refined oil product consumption: -3.6% YoY
• Average Platts Brent H1 2025: USD 71.7/bbl (-14.7% YoY)

China Petroleum & Chemical Corporation (0386.HK) - Profitability Metrics

• Net profit attributable to shareholders (H1 2025): RMB 23.75 billion - a decline of 39.5% to 43.7% vs. H1 2024.
• Basic earnings per share (H1 2025): RMB 0.196, down from RMB 0.415 in H1 2024.
• Operating profit (2024): RMB 70.686 billion; operating profit margin ~2.3% for 2024.
• Total payout ratio (2024): 75%.
• Refining segment revenue decline (2024): -12.2%, driven by lower oil prices.
• Net cash flow from operating activities (2024): RMB 149.360 billion.

• Implication: margins compressed (operating margin ~2.3% in 2024) even as cash conversion remained strong (RMB 149.360 billion), which supports the elevated 75% payout ratio.
• Segment pressure: the refining business saw a 12.2% revenue decline, a primary driver of reduced net profit and EPS in H1 2025.
• Dividend sustainability: high payout ratio amid falling profits raises scrutiny on future distributions if earnings do not recover or cash generation weakens.

China Petroleum & Chemical Corporation (0386.HK) - Debt vs. Equity Structure

Key structural facts and recent capital actions that shape the company's equity base and funding posture as of October 2025.

• Total authorized share capital: RMB 121.28 billion (comprising H shares and A shares).
• Authorized breakdown: 24.05 billion H shares and 97.23 billion A shares - unchanged during October 2025.
• Issued shares (stable as of October 2025): 23.95 billion H shares; 97.23 billion A shares.
• Share repurchases on 28 May 2025: 37.77 million H shares and 48.82 million A shares - not canceled by end-October 2025.
• 2025 capital expenditures: RMB 164.3 billion, with large allocations to upstream (E&P), refining, marketing and chemicals.
• E&P segment capex (2025): RMB 76.7 billion, primarily for construction of crude oil and natural gas production capacity.

• Repurchase rationale: enhances shareholder value per share, offers flexibility in capital structure management (shares held pending cancellation or reissuance).
• CapEx emphasis on E&P signals upstream de-risking and longer-term production growth focus, which may affect future leverage and free cash flow timing.
• Stable issued share counts and unchanged authorized capital indicate no equity dilution events through Oct 2025.

Related company context: Mission Statement, Vision, & Core Values (2026) of China Petroleum & Chemical Corporation.

China Petroleum & Chemical Corporation (0386.HK) - Liquidity and Solvency

Key liquidity and solvency indicators for China Petroleum & Chemical Corporation (0386.HK) through 2024 and the first half of 2025 show robust operating cash generation but weakening profitability and heavy capital deployment that together influence solvency metrics and retained earnings.

• Net cash flow from operating activities: RMB 61.016 billion in H1 2025, up 44.4% year‑on‑year.
• Net cash flow from operating activities: RMB 149.360 billion in full‑year 2024, indicating strong operational cash generation.
• Net profit attributable to shareholders: RMB 23.75 billion in H1 2025, a decrease of 39.5%-43.7% vs. H1 2024.
• Total payout ratio: 75% in 2024, reflecting high distributions to shareholders and pressure on retained earnings.
• Capital expenditures: RMB 164.3 billion in 2025, concentrated in exploration & production, refining, marketing and chemicals.
• Refining segment revenue: down 12.2% (impacting profitability and cash conversion) amid lower oil prices.

Solvency and liquidity considerations:

• Operating cash generation remains a core strength - RMB 149.36 billion in 2024 and RMB 61.016 billion in H1 2025 - which supports near‑term liquidity and funds capital-intensive plans.
• Significant capex (RMB 164.3 billion in 2025) combined with a 75% payout ratio in 2024 tightens retained earnings and may increase reliance on cash flow or external financing for growth projects.
• Declining profitability (net profit down ~40% in H1 2025) and a 12.2% drop in refining revenue reduce internal coverage for debt and dividends, impacting solvency metrics if trends persist.
• Improved operating cash in H1 2025 (+44.4%) partially offsets earnings declines, but capital intensity and dividend policy remain key determinants of balance sheet resilience.

For broader context on the company's background, ownership and business model, see: China Petroleum & Chemical Corporation: History, Ownership, Mission, How It Works & Makes Money

China Petroleum & Chemical Corporation (0386.HK) - Valuation Analysis

• Basic EPS (H1 2025): RMB 0.196 vs RMB 0.415 (H1 2024) - a drop of 52.8% reducing earnings-based multiples.
• Net profit attributable to shareholders (H1 2025): RMB 23.75 billion, down 39.5%-43.7% vs H1 2024 - compresses trailing and forward P/E.
• Total payout ratio (2024): 75% - high cash distribution relative to earnings, affecting retained capital for growth and signaling shareholder returns priority.
• Capital expenditures (2025): RMB 164.3 billion - sizeable investment across upstream, refining, marketing, and chemicals that increases capital intensity and influences EV/EBITDA and FCF trajectories.
• Share repurchases (28 May 2025): 37.77 million H shares and 48.82 million A shares repurchased but not canceled as of end-Oct 2025 - potential EPS accretion if canceled, currently limits immediate share count reduction impact.
• Refining segment revenue change: -12.2% (period referenced) tied to lower oil prices - reduces segment margins and contributes to lower consolidated profitability.

• Valuation implications: lower EPS and net profit widen implied forward P/E under earnings stress; high capex raises EV and can depress near-term free cash flow yields; high payout ratio supports dividend yield but limits reinvestment; pending share cancellations could modestly improve per-share metrics if executed.
• Areas to monitor: EPS recovery trajectory, capex returns (ROIC on 2025 investments), actual cancellation of repurchased shares, and segment recovery in refining and chemicals.

China Petroleum & Chemical Corporation (0386.HK) - Risk Factors

• Commodity price volatility: refining segment revenues fell 12.2% in H1 2025, directly linked to weaker oil prices and refining margins.
• Benchmark oil weakness: average Platts Brent spot price was USD 71.7/bbl in H1 2025, down 14.7% YoY, pressuring revenue from oil-related operations.
• Demand-side pressure: domestic consumption of refined oil products declined 3.6% YoY in H1 2025, reflecting competition from alternative energy and slower fuel demand recovery.
• High capital intensity: 2025 capital expenditures reached RMB 164.3 billion, concentrated in E&P, refining, marketing and chemicals, increasing execution, timing and market risks.
• Share repurchase execution risk: 37.77 million H shares and 48.82 million A shares were repurchased on 28 May 2025 but remained not cancelled as of end-October 2025, creating uncertainty around capital allocation and potential balance-sheet/tax implications.
• Profitability deterioration: net profit attributable to shareholders for H1 2025 was RMB 23.75 billion, a decline of 39.5%-43.7% YoY, indicating operational and margin pressure across segments.

• Liquidity and refinancing: large capex and potential buyback liabilities can increase short-term funding needs or constrain flexibility if cash flows remain pressured.
• Execution risk: aggressive investment in upstream and downstream projects exposes the company to cost overruns, schedule delays and project demand shifts.
• Regulatory & transition risk: accelerating energy transition policies and emissions targets could erode demand for refined products and require higher compliance capital.
• Market sentiment & governance: the outstanding, not-yet-cancelled repurchased shares may affect investor perception of buyback effectiveness and near-term EPS adjustments.

China Petroleum & Chemical Corporation (0386.HK) - Growth Opportunities

• Reserve building: accelerated exploration and appraisal spending to replenish and grow hydrocarbon reserves.
• Production efficiency: optimization across upstream, refining and marketing to lift throughput and product yields.
• Technology adoption: digitalization, enhanced oil recovery (EOR) techniques and low-carbon process upgrades to improve margins and sustainability.

• Capex allocation in 2025 highlights: significant investment across exploration & production, refining, marketing and chemicals to support mid- to long-term growth.
• Operational scale: processing 252 Mt crude and producing 153 Mt refined products in 2024 underpins economies of scale and margin resilience.
• Strong cash generation: RMB 149.360 billion net operating cash flow in 2024 provides internal funding for capex, dividends and share buybacks.